5-Azacytidine: a new active agent for the treatment of acute leukemia.
D000293:Adolescent; D001374:Azacitidine / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D001856:Bone Marrow Examination; D002648:Child; D002675:Child, Preschool; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003562:Cytidine / Q000627:therapeutic use*; D004064:Digestive System / Q000187:drug effects; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D012075:Remission, Spontaneous; D014227:Triazines / Q000627:therapeutic use*
D014227:Triazines; D003562:Cytidine; D001374:Azacitidine; D002746:Chlorpromazine